These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38316672)

  • 1. Quercetin-Loaded Nanostructured Lipid Carrier In Situ Gel for Brain Targeting Through Intranasal Route: Formulation, In Vivo Pharmacokinetic and Pharmacodynamic Studies.
    Sonawane D; Pokharkar V
    AAPS PharmSciTech; 2024 Feb; 25(2):30. PubMed ID: 38316672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
    Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
    Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin.
    Fahmy UA; Ahmed OAA; Badr-Eldin SM; Aldawsari HM; Okbazghi SZ; Awan ZA; Bakhrebah MA; Alomary MN; Abdulaal WH; Medina C; Alhakamy NA
    Int J Nanomedicine; 2020; 15():5253-5264. PubMed ID: 32801690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded
    Mathure D; Ranpise H; Awasthi R; Pawar A
    Assay Drug Dev Technol; 2022 Jul; 20(5):211-224. PubMed ID: 35771865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal delivery of doxepin: enhancing brain targeting efficiency utilizing nanostructured lipid carriers for a biopharmaceutics drug disposition classification system class-I drug.
    Patel HP; Vasandia AV; Jha R; Desai BV; Desai DT; Dedhiya PP; Vyas BA; Maulvi FA
    Pharm Dev Technol; 2024 Jul; 29(6):639-647. PubMed ID: 38980085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.
    Gabal YM; Kamel AO; Sammour OA; Elshafeey AH
    Int J Pharm; 2014 Oct; 473(1-2):442-57. PubMed ID: 25062866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study.
    Pokharkar V; Patil-Gadhe A; Palla P
    Biomed Pharmacother; 2017 Oct; 94():150-164. PubMed ID: 28759752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer's Disease in Rat Model.
    Shehata MK; Ismail AA; Kamel MA
    Int J Nanomedicine; 2023; 18():4193-4227. PubMed ID: 37534058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation.
    Shehata MK; Ismail AA; Kamel MA
    Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer's disease using Box-Behnken design.
    Jojo GM; Kuppusamy G; De A; Karri VVSNR
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1061-1072. PubMed ID: 30922126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy.
    Alam T; Pandit J; Vohora D; Aqil M; Ali A; Sultana Y
    Expert Opin Drug Deliv; 2015 Feb; 12(2):181-94. PubMed ID: 25164097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
    Gadhave DG; Tagalpallewar AA; Kokare CR
    AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ nanostructured hydrogel of resveratrol for brain targeting: in vitro-in vivo characterization.
    Rajput A; Bariya A; Allam A; Othman S; Butani SB
    Drug Deliv Transl Res; 2018 Oct; 8(5):1460-1470. PubMed ID: 29785574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery.
    Chen-yu G; Chun-fen Y; Qi-lu L; Qi T; Yan-wei X; Wei-na L; Guang-xi Z
    Int J Pharm; 2012 Jul; 430(1-2):292-8. PubMed ID: 22486962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nose to Brain Delivery of Rivastigmine by In Situ Gelling Cationic Nanostructured Lipid Carriers: Enhanced Brain Distribution and Pharmacodynamics.
    Wavikar P; Pai R; Vavia P
    J Pharm Sci; 2017 Dec; 106(12):3613-3622. PubMed ID: 28923321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
    Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
    Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured Lipid Carrier-Based Gel for Repurposing Simvastatin in Localized Treatment of Breast Cancer: Formulation Design, Development, and In Vitro and In Vivo Characterization.
    Kumbhar PS; Manjappa AS; Shah RR; Nadaf SJ; Disouza JI
    AAPS PharmSciTech; 2023 Apr; 24(5):106. PubMed ID: 37085596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies.
    Jazuli I; Annu ; Nabi B; Moolakkadath T; Alam T; Baboota S; Ali J
    J Pharm Sci; 2019 Sep; 108(9):3082-3090. PubMed ID: 31077685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine loaded nanostructured lipid carrier for Alzheimer's disease: Design, statistical optimization and enhanced in vivo performance.
    Raju M; Kunde SS; Auti ST; Kulkarni YA; Wairkar S
    Life Sci; 2021 Nov; 285():119990. PubMed ID: 34592234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.